These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32775496)

  • 1. Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter.
    Fong S; Handyside B; Sihn CR; Liu S; Zhang L; Xie L; Murphy R; Galicia N; Yates B; Minto WC; Vitelli C; Harmon D; Ru Y; Yu GK; Escher C; Vowinckel J; Woloszynek J; Akeefe H; Mahimkar R; Bullens S; Bunting S
    Mol Ther Methods Clin Dev; 2020 Sep; 18():620-630. PubMed ID: 32775496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone Does Not Regulate Factor VIII Expression in Mice Receiving AAV5-hFVIII-SQ: Valoctocogene Roxaparvovec.
    Zhang L; Handyside B; Murphy R; Sihn CR; Xie L; Vitelli C; Harmon D; Sisó S; Liu S; Bullens S; Bunting S; Fong S
    Mol Ther Methods Clin Dev; 2020 Jun; 17():13-20. PubMed ID: 31890737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of AAV5-hFVIII-SQ vector-genome-processing kinetics in transduced mouse and nonhuman primate livers.
    Sihn CR; Handyside B; Liu S; Zhang L; Murphy R; Yates B; Xie L; Torres R; Russell CB; O'Neill CA; Pungor E; Bunting S; Fong S
    Mol Ther Methods Clin Dev; 2022 Mar; 24():142-153. PubMed ID: 35036471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A.
    Fong S; Yates B; Sihn CR; Mattis AN; Mitchell N; Liu S; Russell CB; Kim B; Lawal A; Rangarajan S; Lester W; Bunting S; Pierce GF; Pasi KJ; Wong WY
    Nat Med; 2022 Apr; 28(4):789-797. PubMed ID: 35411075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young mice administered adult doses of AAV5-hFVIII-SQ achieve therapeutic factor VIII expression into adulthood.
    Zhang L; Yates B; Murphy R; Liu S; Xie L; Handyside B; Sihn CR; Bouwman T; Galicia N; Tan D; Fonck C; Arens J; Clark A; Zhang W; Chandra S; Srimani J; Holcomb J; Van Tuyl A; Henshaw J; Vettermann C; Siso S; Su C; Bullens S; Bunting S; O'Neill C; Fong S
    Mol Ther Methods Clin Dev; 2022 Sep; 26():519-531. PubMed ID: 36092364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of germline transmission in male mice following a single intravenous administration of AAV5-hFVIII-SQ gene therapy.
    Fonck C; Su C; Arens J; Koziol E; Srimani J; Henshaw J; Van Tuyl A; Chandra S; Vettermann C; O'Neill CA
    Gene Ther; 2023 Aug; 30(7-8):581-586. PubMed ID: 35132205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A.
    Long BR; Veron P; Kuranda K; Hardet R; Mitchell N; Hayes GM; Wong WY; Lau K; Li M; Hock MB; Zoog SJ; Vettermann C; Mingozzi F; Schweighardt B
    Mol Ther; 2021 Feb; 29(2):597-610. PubMed ID: 33309883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
    Pasi KJ; Rangarajan S; Mitchell N; Lester W; Symington E; Madan B; Laffan M; Russell CB; Li M; Pierce GF; Wong WY
    N Engl J Med; 2020 Jan; 382(1):29-40. PubMed ID: 31893514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of
    Liu S; Razon L; Ritchie O; Sihn CR; Handyside B; Berguig G; Woloszynek J; Zhang L; Batty P; Lillicrap D; Agrawal V; Cortesio C; Gebretsadik K; Akeefe H; Colosi P; Kim B; Bunting S; Fong S
    Mol Ther Methods Clin Dev; 2022 Sep; 26():61-71. PubMed ID: 35782594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapy.
    Rosen S; Tiefenbacher S; Robinson M; Huang M; Srimani J; Mackenzie D; Christianson T; Pasi KJ; Rangarajan S; Symington E; Giermasz A; Pierce GF; Kim B; Zoog SJ; Vettermann C
    Blood; 2020 Nov; 136(22):2524-2534. PubMed ID: 32915950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression.
    Handyside B; Zhang L; Yates B; Xie L; Ismail AM; Murphy R; Baridon B; Su C; Bouwman T; Mangini L; Tahquechi J; Salcido S; Minto WC; Keenan WT; Ntai I; Sihn CR; Bullens S; Bunting S; Fong S
    Hum Gene Ther; 2024 Jan; 35(1-2):36-47. PubMed ID: 38126359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    Ozelo MC; Mahlangu J; Pasi KJ; Giermasz A; Leavitt AD; Laffan M; Symington E; Quon DV; Wang JD; Peerlinck K; Pipe SW; Madan B; Key NS; Pierce GF; O'Mahony B; Kaczmarek R; Henshaw J; Lawal A; Jayaram K; Huang M; Yang X; Wong WY; Kim B;
    N Engl J Med; 2022 Mar; 386(11):1013-1025. PubMed ID: 35294811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.
    Nguyen GN; George LA; Siner JI; Davidson RJ; Zander CB; Zheng XL; Arruda VR; Camire RM; Sabatino DE
    J Thromb Haemost; 2017 Jan; 15(1):110-121. PubMed ID: 27749002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy.
    Long BR; Sandza K; Holcomb J; Crockett L; Hayes GM; Arens J; Fonck C; Tsuruda LS; Schweighardt B; O'Neill CA; Zoog S; Vettermann C
    Mol Ther Methods Clin Dev; 2019 Jun; 13():440-452. PubMed ID: 31193016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A.
    Long BR; Robinson TM; Day JRS; Yu H; Lau K; Imtiaz U; Patton KS; de Hart G; Henshaw J; Agarwal S; Vettermann C; Zoog SJ; Gupta S
    Mol Ther; 2024 Jul; 32(7):2052-2063. PubMed ID: 38796703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
    McIntosh J; Lenting PJ; Rosales C; Lee D; Rabbanian S; Raj D; Patel N; Tuddenham EG; Christophe OD; McVey JH; Waddington S; Nienhuis AW; Gray JT; Fagone P; Mingozzi F; Zhou SZ; High KA; Cancio M; Ng CY; Zhou J; Morton CL; Davidoff AM; Nathwani AC
    Blood; 2013 Apr; 121(17):3335-44. PubMed ID: 23426947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice.
    Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM
    Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cleavage of human factor VIII at the B-domain and acidic region 3 interface enhances expression after gene therapy in hemophilia A mice.
    Nguyen GN; Lindgren JR; Seleme MC; Kafle S; Zander CB; Zheng XL; Sabatino DE
    J Thromb Haemost; 2023 Aug; 21(8):2101-2113. PubMed ID: 37080538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
    Rangarajan S; Walsh L; Lester W; Perry D; Madan B; Laffan M; Yu H; Vettermann C; Pierce GF; Wong WY; Pasi KJ
    N Engl J Med; 2017 Dec; 377(26):2519-2530. PubMed ID: 29224506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Adeno-Associated Viral-Mediated Human Factor VIII Gene Therapy in Cynomolgus Macaques.
    Greig JA; Nordin JML; White JW; Wang Q; Bote E; Goode T; Calcedo R; Wadsworth S; Wang L; Wilson JM
    Hum Gene Ther; 2018 Jul; ():. PubMed ID: 29890905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.